Us Bancorp \De\ Novo Cure LTD Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Novo Cure LTD stock. As of the latest transaction made, Us Bancorp \De\ holds 5,757 shares of NVCR stock, worth $158,029. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,757

Previous 7,003 17.79%

Holding current value

$158,029

Previous $119,000 25.21%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$15.61 - $23.34 $19,450 - $29,081	-1,246 Reduced 17.79%	5,757 $89,000
Q2 2024 Aug 06, 2024	BUY	$11.83 - $24.05 $29,172 - $59,307	2,466 Added 54.35%	7,003 $119,000
Q1 2024 May 07, 2024	BUY	$12.42 - $17.29 $9,936 - $13,832	800 Added 21.41%	4,537 $70,000
Q4 2023 Feb 09, 2024	BUY	$11.13 - $15.78 $13,122 - $18,604	1,179 Added 46.09%	3,737 $55,000
Q3 2023 Nov 03, 2023	BUY	$16.15 - $42.35 $18,992 - $49,803	1,176 Added 85.09%	2,558 $41,000
Q2 2023 Aug 09, 2023	SELL	$40.29 - $82.51 $4,955 - $10,148	-123 Reduced 8.17%	1,382 $57,000
Q1 2023 May 09, 2023	BUY	$56.44 - $118.81 $7,845 - $16,514	139 Added 10.18%	1,505 $90,000
Q4 2022 Feb 13, 2023	SELL	$63.98 - $85.37 $77,927 - $103,980	-1,218 Reduced 47.14%	1,366 $100,000
Q3 2022 Oct 27, 2022	SELL	$67.99 - $89.57 $4,759 - $6,269	-70 Reduced 2.64%	2,584 $197,000
Q2 2022 Aug 01, 2022	SELL	$56.6 - $89.9 $11,489 - $18,249	-203 Reduced 7.11%	2,654 $185,000
Q1 2022 May 11, 2022	BUY	$60.15 - $84.52 $27,308 - $38,372	454 Added 18.89%	2,857 $237,000
Q4 2021 Feb 11, 2022	BUY	$75.08 - $121.99 $12,463 - $20,250	166 Added 7.42%	2,403 $180,000
Q3 2021 Nov 10, 2021	SELL	$116.17 - $194.55 $124,418 - $208,363	-1,071 Reduced 32.38%	2,237 $260,000
Q2 2021 Aug 05, 2021	BUY	$130.4 - $225.58 $56,072 - $96,999	430 Added 14.94%	3,308 $734,000
Q1 2021 Apr 28, 2021	BUY	$124.11 - $190.17 $15,141 - $23,200	122 Added 4.43%	2,878 $381,000
Q4 2020 Feb 04, 2021	SELL	$112.16 - $174.14 $728,591 - $1.13 Million	-6,496 Reduced 70.21%	2,756 $476,000
Q3 2020 Nov 10, 2020	SELL	$58.05 - $111.31 $812 - $1,558	-14 Reduced 0.15%	9,252 $1.03 Million
Q2 2020 Aug 07, 2020	SELL	$57.2 - $74.41 $57,657 - $75,005	-1,008 Reduced 9.81%	9,266 $549,000
Q1 2020 May 13, 2020	SELL	$57.05 - $95.75 $19,225 - $32,267	-337 Reduced 3.18%	10,274 $692,000
Q4 2019 Feb 04, 2020	SELL	$68.3 - $93.8 $20,490 - $28,140	-300 Reduced 2.75%	10,611 $894,000
Q3 2019 Nov 08, 2019	SELL	$61.86 - $97.8 $129,225 - $204,304	-2,089 Reduced 16.07%	10,911 $816,000
Q2 2019 Aug 13, 2019	SELL	$42.22 - $63.23 $21,110 - $31,615	-500 Reduced 3.7%	13,000 $822,000
Q4 2018 Feb 13, 2019	BUY	$28.72 - $52.63 $14,360 - $26,315	500 Added 3.85%	13,500 $452,000
Q3 2017 Nov 13, 2017	BUY	$18.05 - $21.75 $234,650 - $282,750	13,000	13,000 $258,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.88B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account